The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Autoimmune Diseases Treatment-Global Market Insights and Sales Trends 2024
Synopsis
The global Autoimmune Diseases Treatment market size is expected to reach US$ 141030 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Diseases Treatment in various end use industries. The expanding demands from the Hospital, Medical Center and Other, are propelling Autoimmune Diseases Treatment market. Blood Transfusion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supplements segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Diseases Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Diseases Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Diseases Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Diseases Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Diseases Treatment covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly, AstraZeneca, Lupin, Amgen, Bristol-Myers Squibb, AutoImmune and Pfizer, etc.
The global Autoimmune Diseases Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
GlaxoSmithKline
F. Hoffmann-La Roche
Johnson & Johnson
Global Autoimmune Diseases Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Diseases Treatment market, Segment by Type:
Blood Transfusion
Supplements
Drugs
Physical Therapy
Other
Global Autoimmune Diseases Treatment market, by Application
Hospital
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Diseases Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Autoimmune Diseases Treatment market size is expected to reach US$ 141030 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Diseases Treatment in various end use industries. The expanding demands from the Hospital, Medical Center and Other, are propelling Autoimmune Diseases Treatment market. Blood Transfusion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supplements segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Diseases Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Diseases Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Diseases Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Diseases Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Diseases Treatment covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly, AstraZeneca, Lupin, Amgen, Bristol-Myers Squibb, AutoImmune and Pfizer, etc.
The global Autoimmune Diseases Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
GlaxoSmithKline
F. Hoffmann-La Roche
Johnson & Johnson
Global Autoimmune Diseases Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Diseases Treatment market, Segment by Type:
Blood Transfusion
Supplements
Drugs
Physical Therapy
Other
Global Autoimmune Diseases Treatment market, by Application
Hospital
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Diseases Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Autoimmune Diseases Treatment
1.1 Autoimmune Diseases Treatment Market Overview
1.1.1 Autoimmune Diseases Treatment Product Scope
1.1.2 Autoimmune Diseases Treatment Market Status and Outlook
1.2 Global Autoimmune Diseases Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autoimmune Diseases Treatment Market Size by Region (2018-2029)
1.4 Global Autoimmune Diseases Treatment Historic Market Size by Region (2018-2023)
1.5 Global Autoimmune Diseases Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autoimmune Diseases Treatment Market Size (2018-2029)
1.6.1 North America Autoimmune Diseases Treatment Market Size (2018-2029)
1.6.2 Europe Autoimmune Diseases Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Autoimmune Diseases Treatment Market Size (2018-2029)
1.6.4 Latin America Autoimmune Diseases Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Autoimmune Diseases Treatment Market Size (2018-2029)
2 Autoimmune Diseases Treatment Market by Type
2.1 Introduction
2.1.1 Blood Transfusion
2.1.2 Supplements
2.1.3 Drugs
2.1.4 Physical Therapy
2.1.5 Other
2.2 Global Autoimmune Diseases Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autoimmune Diseases Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autoimmune Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autoimmune Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autoimmune Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autoimmune Diseases Treatment Revenue Breakdown by Type (2018-2029)
3 Autoimmune Diseases Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Medical Center
3.1.3 Other
3.2 Global Autoimmune Diseases Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Autoimmune Diseases Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Autoimmune Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Autoimmune Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Autoimmune Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Autoimmune Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Autoimmune Diseases Treatment Revenue Breakdown by Application (2018-2029)
4 Autoimmune Diseases Treatment Competition Analysis by Players
4.1 Global Autoimmune Diseases Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Diseases Treatment as of 2022)
4.3 Date of Key Players Enter into Autoimmune Diseases Treatment Market
4.4 Global Top Players Autoimmune Diseases Treatment Headquarters and Area Served
4.5 Key Players Autoimmune Diseases Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Diseases Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Autoimmune Diseases Treatment Products, Services and Solutions
5.1.4 Abbott Laboratories Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Active Biotech
5.2.1 Active Biotech Profile
5.2.2 Active Biotech Main Business
5.2.3 Active Biotech Autoimmune Diseases Treatment Products, Services and Solutions
5.2.4 Active Biotech Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Active Biotech Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Autoimmune Diseases Treatment Products, Services and Solutions
5.3.4 Eli Lilly Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Autoimmune Diseases Treatment Products, Services and Solutions
5.4.4 AstraZeneca Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Lupin
5.5.1 Lupin Profile
5.5.2 Lupin Main Business
5.5.3 Lupin Autoimmune Diseases Treatment Products, Services and Solutions
5.5.4 Lupin Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Lupin Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Autoimmune Diseases Treatment Products, Services and Solutions
5.6.4 Amgen Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Autoimmune Diseases Treatment Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 AutoImmune
5.8.1 AutoImmune Profile
5.8.2 AutoImmune Main Business
5.8.3 AutoImmune Autoimmune Diseases Treatment Products, Services and Solutions
5.8.4 AutoImmune Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 AutoImmune Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Autoimmune Diseases Treatment Products, Services and Solutions
5.9.4 Pfizer Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Profile
5.10.2 GlaxoSmithKline Main Business
5.10.3 GlaxoSmithKline Autoimmune Diseases Treatment Products, Services and Solutions
5.10.4 GlaxoSmithKline Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 GlaxoSmithKline Recent Developments
5.11 F. Hoffmann-La Roche
5.11.1 F. Hoffmann-La Roche Profile
5.11.2 F. Hoffmann-La Roche Main Business
5.11.3 F. Hoffmann-La Roche Autoimmune Diseases Treatment Products, Services and Solutions
5.11.4 F. Hoffmann-La Roche Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 F. Hoffmann-La Roche Recent Developments
5.12 Johnson & Johnson
5.12.1 Johnson & Johnson Profile
5.12.2 Johnson & Johnson Main Business
5.12.3 Johnson & Johnson Autoimmune Diseases Treatment Products, Services and Solutions
5.12.4 Johnson & Johnson Autoimmune Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Johnson & Johnson Recent Developments
6 North America
6.1 North America Autoimmune Diseases Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autoimmune Diseases Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Diseases Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Diseases Treatment Market Dynamics
11.1 Autoimmune Diseases Treatment Industry Trends
11.2 Autoimmune Diseases Treatment Market Drivers
11.3 Autoimmune Diseases Treatment Market Challenges
11.4 Autoimmune Diseases Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
